Concentrix Corporation

NASDAQ:CNXC

64.17 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 2,380.7162,402.7482,230.7621,632.8341,614.7061,636.4041,640.7181,579.6021,568.1011,536.0521,466.6081,397.2511,369.8781,353.2781,300.8581,163.6931,066.3621,188.621,212.8361,160.9281,160.8771,173.271
Cost of Revenue 1,699.5191,730.7331,407.9051,039.1421,034.4811,055.2431,047.3531,012.7541,009.185997.918947.24915.91887.149867.228842.226751.161721.193743.429754.405734.747730.35739.962
Gross Profit 681.197672.015822.857593.692580.225581.161593.365566.848558.916538.134519.368481.341482.729486.05458.632412.532345.169445.191458.431426.181430.527433.309
Gross Profit Ratio 0.2860.280.3690.3640.3590.3550.3620.3590.3560.350.3540.3440.3520.3590.3530.3550.3240.3750.3780.3670.3710.369
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 0000000000000000000000
Selling & Marketing Expenses 0000000000000000000000
SG&A 499.458493.98642.41431.425417.659425.114415.375409.303402.004390.389361.463329.962354.505351.161338.425335.77321.59356.979356.977346.956352.551345.201
Other Expenses 19.4156.824-32.829-6.169-9.383-3.71412.6412.0862.5457.6160.7445.8583.546-3.8033.164-0.5931.6413.235-0.401000
Operating Expenses 499.458493.98642.41431.425417.659425.114415.375409.303402.004390.389361.463329.962354.505351.161338.425335.77321.59356.979356.977353.706367.683373.069
Operating Income 181.739178.035180.447162.267162.56674.898112.22691.19780.85181.268157.905151.379128.224134.889120.20776.76323.5888.211101.45479.22577.97688.108
Operating Income Ratio 0.0760.0740.0810.0990.1010.0460.0680.0580.0520.0530.1080.1080.0940.10.0920.0660.0220.0740.0840.0680.0670.075
Total Other Income Expenses Net -94.611-105.211-32.829-6.169-56.59643.44550.34358.16265.63365.3230.7445.8583.546-3.8033.164-0.5931.6413.235-0.401-31.919-38.834-50.967
Income Before Tax 87.12872.82477.11106.805105.97118.343162.569149.359146.484146.591154.919152.369125.025123.383114.57367.16812.29373.86180.82747.30639.14237.141
Income Before Tax Ratio 0.0370.030.0350.0650.0660.0720.0990.0950.0930.0950.1060.1090.0910.0910.0880.0580.0120.0620.0670.0410.0340.032
Income Tax Expense 20.29420.7227.62329.1727.1230.47357.62542.23533.45136.05230.81142.61542.12134.57249.94621.7719.82321.54448.95716.97517.9033.417
Net Income 66.83452.10269.48777.63578.8587.87104.944106.69113.142110.273124.108109.75482.90488.81164.62745.3972.4752.31731.8730.33121.23933.724
Net Income Ratio 0.0280.0220.0310.0480.0490.0540.0640.0680.0720.0720.0850.0790.0610.0660.050.0390.0020.0440.0260.0260.0180.029
EPS 0.980.761.11.51.511.692.022.082.192.122.372.11.591.721.250.880.0481.010.620.5880.4120.654
EPS Diluted 0.980.761.091.491.511.682.012.072.182.122.352.081.571.691.250.880.0481.010.620.5870.4110.652
EBITDA 358.682362.095303.085156.098153.183152.333190.63169.631159.457155.361158.649157.237131.77131.086123.371144.51291.763160.24175.129153.903156.991166.119
EBITDA Ratio 0.1510.1510.1360.0960.0950.0930.1160.1070.1020.1010.1080.1130.0960.0970.0950.1240.0860.1350.1440.1330.1350.142